HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells

References

• Field KM, Rosenthal MA, Yilmaz M, Tacey M, Drummond K. Comparison between poor and long-term survivors with glioblastoma: Review of an Australian dataset. Asia Pac J Clin Oncol 2013; Forthcoming http://dx.doi.org/10.1111/ajco.12076; PMID: 23701649
   PubMed Web of Science ®Google Scholar
• Juratli TA, Schackert G, Krex D. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Pharmacol Ther 2013; 139:341 - 58; http://dx.doi.org/10.1016/j.pharmthera.2013.05.003; PMID: 23694764
   PubMed Web of Science ®Google Scholar
• Jiang C, Wang H, Kang Q, Liu J, Bai L. Cloning and characterization of the polyether salinomycin biosynthesis gene cluster of Streptomyces albus XM211. Appl Environ Microbiol 2012; 78:994 - 1003; http://dx.doi.org/10.1128/AEM.06701-11; PMID: 22156425
   PubMed Web of Science ®Google Scholar
• Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138:645 - 59; http://dx.doi.org/10.1016/j.cell.2009.06.034; PMID: 19682730
   PubMed Web of Science ®Google Scholar
• Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH. Salinomycin selectively targets ‘CD133+’ cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011; 18:1797 - 804; http://dx.doi.org/10.1245/s10434-011-1561-2; PMID: 21267784
   PubMed Web of Science ®Google Scholar
• Rollinson J, Taylor FG, Chesney J. Salinomycin poisoning in horses. Vet Rec 1987; 121:126 - 8; http://dx.doi.org/10.1136/vr.121.6.126; PMID: 3672848
   PubMed Web of Science ®Google Scholar
• Oehme FW, Pickrell JA. An analysis of the chronic oral toxicity of polyether ionophore antibiotics in animals. Vet Hum Toxicol 1999; 41:251 - 7; PMID: 10434384
   PubMedGoogle Scholar
• Boehmerle W, Endres M. Salinomycin induces calpain and cytochrome c-mediated neuronal cell death. Cell Death Dis 2011; 2:e168; http://dx.doi.org/10.1038/cddis.2011.46; PMID: 21633391
   PubMed Web of Science ®Google Scholar
• Szkudlarek-Mikho M, Saunders RA, Yap SF, Ngeow YF, Chin KV. Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis. Biochem Biophys Res Commun 2012; 428:487 - 93; http://dx.doi.org/10.1016/j.bbrc.2012.10.080; PMID: 23123626
   PubMed Web of Science ®Google Scholar
• Lattanzio FA Jr., Pressman BC. Alterations in intracellular calcium activity and contractility of isolated perfused rabbit hearts by ionophores and adrenergic agents. Biochem Biophys Res Commun 1986; 139:816 - 21; http://dx.doi.org/10.1016/S0006-291X(86)80063-8; PMID: 3767987
   PubMed Web of Science ®Google Scholar
• Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, Song CS, Chatterjee B, Ahn SC. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 2011; 413:80 - 6; http://dx.doi.org/10.1016/j.bbrc.2011.08.054; PMID: 21871443
   PubMed Web of Science ®Google Scholar
• Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A, Mirmohammadsadegh A. Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLoS One 2012; 7:e44132; http://dx.doi.org/10.1371/journal.pone.0044132; PMID: 23028492
   PubMed Web of Science ®Google Scholar
• Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson BA, Rao Pariti RK, Cieślar-Pobuda A, Panigrahi S, Łos MJ. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta 2013; 1833:2057 - 69; http://dx.doi.org/10.1016/j.bbamcr.2013.04.011; PMID: 23639289
   PubMed Web of Science ®Google Scholar
• Michaelis M, Doerr HW, Cinatl J Jr.. Valproic acid as anti-cancer drug. Curr Pharm Des 2007; 13:3378 - 93; http://dx.doi.org/10.2174/138161207782360528; PMID: 18045192
   PubMed Web of Science ®Google Scholar
• Atadja PW. HDAC inhibitors and cancer therapy. Prog Drug Res 2011; 67:175 - 95; PMID: 21141730
   PubMedGoogle Scholar
• Barbone D, Cheung P, Battula S, Busacca S, Gray SG, Longley DB, Bueno R, Sugarbaker DJ, Fennell DA, Broaddus VC. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One 2012; 7:e52753; http://dx.doi.org/10.1371/journal.pone.0052753; PMID: 23300762
   PubMed Web of Science ®Google Scholar
• Premkumar DR, Jane EP, Agostino NR, DiDomenico JD, Pollack IF. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. Mol Carcinog 2013; 52:118 - 33; http://dx.doi.org/10.1002/mc.21835; PMID: 22086447
   PubMed Web of Science ®Google Scholar
• Shubassi G, Robert T, Vanoli F, Minucci S, Foiani M. Acetylation: a novel link between double-strand break repair and autophagy. Cancer Res 2012; 72:1332 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-11-3172; PMID: 22422989
   PubMed Web of Science ®Google Scholar
• Jeong SG, Ohn T, Kim SH, Cho GW. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells. Neurosci Lett 2013; 554:22 - 7; http://dx.doi.org/10.1016/j.neulet.2013.08.059; PMID: 24021810
   PubMed Web of Science ®Google Scholar
• Guthrie GD, Eljamel S. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg 2013; 118:859 - 65; http://dx.doi.org/10.3171/2012.10.JNS12169; PMID: 23176328
   PubMed Web of Science ®Google Scholar
• Cruickshanks N, Hamed HA, Booth L, Tavallai S, Syed J, Sajithlal GB, Grant S, Poklepovic A, Dent P. Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy. Cancer Biol Ther 2013; 14:982 - 96; http://dx.doi.org/10.4161/cbt.26234; PMID: 24025251
   PubMed Web of Science ®Google Scholar
• Tang Y, Yacoub A, Hamed HA, Poklepovic A, Tye G, Grant S, Dent P. Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells. Cancer Biol Ther 2012; 13:567 - 74; http://dx.doi.org/10.4161/cbt.19771; PMID: 22406992
   PubMed Web of Science ®Google Scholar
• Park MA, Reinehr R, Häussinger D, Voelkel-Johnson C, Ogretmen B, Yacoub A, Grant S, Dent P. Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells. Mol Cancer Ther 2010; 9:2220 - 31; http://dx.doi.org/10.1158/1535-7163.MCT-10-0274; PMID: 20682655
   PubMed Web of Science ®Google Scholar
• Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, Kellert B, Gollnick H, Silke J, Leverkus M. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 2009; 187:1037 - 54; http://dx.doi.org/10.1083/jcb.200904158; PMID: 20038679
   PubMed Web of Science ®Google Scholar
• Booth L, Cruickshanks N, Ridder T, Dai Y, Grant S, Dent P. PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells. Cancer Biol Ther 2013; 14:458 - 65; http://dx.doi.org/10.4161/cbt.24424; PMID: 23917378
   PubMed Web of Science ®Google Scholar
• Sajithlal GB, Hamed HA, Cruickshanks N, Booth L, Tavallai S, Syed J, Grant S, Poklepovic A, Dent P. Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells. Mol Pharmacol 2013; 84:562 - 71; http://dx.doi.org/10.1124/mol.113.088005; PMID: 23877009
   PubMed Web of Science ®Google Scholar
• Hamed HA, Yacoub A, Park MA, Archer K, Das SK, Sarkar D, Grant S, Fisher PB, Dent P. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells. Mol Pharmacol 2013; 84:171 - 81; http://dx.doi.org/10.1124/mol.113.086553; PMID: 23661648
   PubMed Web of Science ®Google Scholar
• Bareford MD, Hamed HA, Allegood J, Cruickshanks N, Poklepovic A, Park MA, Ogretmen B, Spiegel S, Grant S, Dent P. Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biol Ther 2012; 13:793 - 803; http://dx.doi.org/10.4161/cbt.20562; PMID: 22673740
   PubMed Web of Science ®Google Scholar
• Rojas E, Lopez MC, Valverde M. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl 1999; 722:225 - 54; http://dx.doi.org/10.1016/S0378-4347(98)00313-2; PMID: 10068143
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sugiyama C, Morikawa Y, Hayashi M, Sofuni T. MMS Commun 1995; 3:103 - 15
   Google Scholar